Filing Details

Accession Number:
0001610717-24-000231
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-07 17:05:52
Reporting Period:
2024-05-06
Accepted Time:
2024-05-07 17:05:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626971 Corvus Pharmaceuticals Inc. CRVS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1031847 Md A Richard Miller C/O Corvus Pharmaceuticals, Inc.
863 Mitten Road, Suite 102
Burlingame CA 94010
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-06 577,634 $1.73 577,634 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (Right to Buy) Acquisiton 2024-05-06 559,073 $0.00 559,073 $3.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
559,073 2024-05-06 2025-06-30 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,490,119 Indirect By Trust
Footnotes
  1. These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
  2. Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.